|
Volumn 152, Issue 46, 2008, Pages 2507-2511
|
Guideline 'Treatment of breast cancer 2008' (revision);Richtlijn 'Behandeling van het mammacarcinoom 2008' (herziening)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTHRACYCLINE;
BEVACIZUMAB;
BRCA1 PROTEIN;
BRCA2 PROTEIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIRUBICIN;
FLUOROURACIL;
METHOTREXATE;
TAMOXIFEN;
TRASTUZUMAB;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER RADIOTHERAPY;
CANCER SCREENING;
EVIDENCE BASED MEDICINE;
GENE MUTATION;
HUMAN;
MASTECTOMY;
MONOTHERAPY;
PRACTICE GUIDELINE;
PROGNOSIS;
SHORT SURVEY;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
MASTECTOMY;
NEOADJUVANT THERAPY;
NEOPLASM STAGING;
NETHERLANDS;
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES AS TOPIC;
PROGNOSIS;
SOCIETIES, MEDICAL;
TREATMENT OUTCOME;
|
EID: 56549111759
PISSN: 00282162
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (13)
|
References (0)
|